U.S. Markets closed

Bio-Solutions Corp Announces Type2 Defense(tm) Infomercial Set To Run With Rollout in January

SAN ANTONIO, TEXAS / ACCESSWIRE / December 23, 2013 / Bio-Solutions Corp. (BISU) announced today that its Type2 Defense(tm) Infomercial is set to run with rollout in January 2014.

A snippet of the completed infomercial is now available and can be viewed here: https://vimeo.com/81549711

Type2 Defense™ powder blend is a safe and natural supplement that may assist in the stabilization of healthy glucose levels as well as provide strong antioxidants. This all natural pure powder mix contains green tea, cinnamon extract (cinnulinPF) and blueberry flavors, and the Type2 Defense™ proprietary blend. When mixed with water, this flavorful supplement becomes a delicious and effective tool.

Affecting millions of Americans, Type 2 Diabetes is the most common form of diabetes. BioSolutions Corp introduces Type 2 Defense™, a powder blend of natural ingredients that has been developed to help support healthy blood glucose levels in health-conscious individuals and those diagnosed with Pre-diabetes and Type II Diabetes.

“This company recognizes the diabetic epidemic that is happening in this country and throughout the world. We are excited to offer such a dynamic nutritional supplement that supports healthy living in the diabetic community”, says CEO Bill Gallagher. The company’s focus is now on type 2 and pre-diabetic products.

Type2 Defense™ proprietary blend was developed by Dr. Chandrasekhar Mallangi. Dr. Mallangi is a former Nestle’ USA nutritional Innovator and Developer of multiple Nestle’ USA Product lines named the Company’s Chief Scientist at Bio-Solutions Corp. “We are very pleased to surround ourselves with high caliber people as Dr. Mallangi. As a fellow Scientist, I can appreciate the work and dedication that has brought us to this point.” Stated Gilles Chaumillion, Former President and CEO.

Type2 Defense™ is a nutritional supplement delivered in 6.89 gram plastic packets conveniently packaged in a box of 30 servings. Product statements have not been evaluated by the FDA. The products are not intended to diagnose, treat, cure or prevent disease.

About Bio-Solutions Corp.

Bio-Solutions Corp. markets new and very effective organic products; our lead product is Type2 Defense™. Type2Defense™ a Diabetic Supplement Drink. Type2Defense™ is a new dietary supplement that has been developed to help support healthy blood glucose levels in health-conscious individuals and those diagnosed with Type 2 Diabetes, when substituted over many popular sugar and/orcarbohydrate-laden alternatives. The Product's goal is to provide a safe and natural supplement that will assist in the stabilization of healthy glucose levels along with providing strong antioxidants and low carbohydrates.

Consumers can find more information about the company and its products by going to http://www.biosolutionscorp.com/.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management's views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as management "believes", "expects", "anticipates", "foresees", "forecasts", "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-lookingstatements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.


Bill Gallagher, President & CEO
Bio-Solutions Corp.

Investor Relations Contact
William Gallagher

Source: Bio-Solutions Corp.